BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21630545)

  • 1. [Strategies for development of new influenza medication].
    Steinmetzer T
    Pharm Unserer Zeit; 2011 Mar; 40(2):160-8. PubMed ID: 21630545
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions.
    Palù G; Loregian A
    Antiviral Res; 2013 Sep; 99(3):318-27. PubMed ID: 23748148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibitors of influenza virus replication as potential chemoprophylactic agents.
    Oxford JS
    J Antimicrob Chemother; 1975 Mar; 1(1):7-23. PubMed ID: 1100585
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of siRNAs to prevent and treat influenza virus infection.
    Ge Q; Eisen HN; Chen J
    Virus Res; 2004 Jun; 102(1):37-42. PubMed ID: 15068878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral strategies against influenza virus: towards new therapeutic approaches.
    Loregian A; Mercorelli B; Nannetti G; Compagnin C; Palù G
    Cell Mol Life Sci; 2014 Oct; 71(19):3659-83. PubMed ID: 24699705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of fullerene C60-polyvinilpyrrolidone complexes on influenza virus reproduction].
    Piotrovskiĭ LB; Kozeletskaia KN; Medvedeva NA; Dumpis MA; Pozniakova LI; Kiselev OI
    Vopr Virusol; 2001; 46(3):38-42. PubMed ID: 11450143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza chemotherapy: a review of the present state of art and of new drugs in development.
    Lüscher-Mattli M
    Arch Virol; 2000; 145(11):2233-48. PubMed ID: 11205114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical need for new antiviral drugs directed against influenza virus.
    McCullers JA
    J Infect Dis; 2006 Mar; 193(6):751-3. PubMed ID: 16479505
    [No Abstract]   [Full Text] [Related]  

  • 9. The push for better flu therapies.
    Savage N
    Nature; 2019 Sep; 573(7774):S54-S55. PubMed ID: 31534252
    [No Abstract]   [Full Text] [Related]  

  • 10. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of anti-influenza drug].
    Zhang T; Wang CY; Gao YW; Yang ST; Wang TC; Xia XZ
    Bing Du Xue Bao; 2011 Sep; 27(5):475-80. PubMed ID: 21998961
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus.
    Meneghesso S; Vanderlinden E; Stevaert A; McGuigan C; Balzarini J; Naesens L
    Antiviral Res; 2012 Apr; 94(1):35-43. PubMed ID: 22306172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.
    Tomassini J; Selnick H; Davies ME; Armstrong ME; Baldwin J; Bourgeois M; Hastings J; Hazuda D; Lewis J; McClements W
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2827-37. PubMed ID: 7695269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genome structure, transcription and replication of influenza virus].
    Ishihama A
    Uirusu; 1990 Jun; 40(1):33-7. PubMed ID: 2288068
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapeutic control of influenza.
    Stephenson I; Nicholson KG
    J Antimicrob Chemother; 1999 Jul; 44(1):6-10. PubMed ID: 10459804
    [No Abstract]   [Full Text] [Related]  

  • 17. [Target of developing the new anti-influenza virus reagents].
    Toyoda T
    Nihon Rinsho; 2003 Nov; 61(11):1980-6. PubMed ID: 14619442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Implications of Antiviral Resistance in Influenza.
    Li TC; Chan MC; Lee N
    Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-influenza virus activity of biflavonoids.
    Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
    Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influenza becomes treatable. Breakthrough against the last great epidemic?].
    Einecke D
    MMW Fortschr Med; 1999 Dec; 141(49-50):4-6. PubMed ID: 10726138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.